Concepedia

Deepa Rangachari

DR

6

Publications

471

Citations

6

H-Index

2011

Active since

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Dana-Farber Cancer Institute

Deepa Rangachari is an author at Harvard University specializing in oncology, medicine, and lung cancer.

Top concepts

Publications per year

2011–2021

6

Publications

6

Association of Performance Status With Survival in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy

Kartik Sehgal, Ritu R. Gill, Page Widick et al. · JAMA Network Open · 2021 · 157 citations · Full text

Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival

George J. Arnaoutakis, Deepa Rangachari, Daniel A. Laheru et al. · Journal of Gastrointestinal Surgery · 2011 · 155 citations · Full text

, , +7

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

Rebecca Karp Leaf, Christopher Ferreri, Deepa Rangachari et al. · American Journal of Hematology · 2019 · 73 citations · Full text

, , +20

Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature

Camille R. Petri, Rushad Patell, Felipe Batalini et al. · Respiratory Medicine Case Reports · 2019 · 40 citations · Full text

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors

Xiuning Le, Neelam V. Desai, Adnan Majid et al. · Lung Cancer · 2015 · 34 citations · Full text

, , +7

Rows per page

1–5 of 6